儿童急性药物暴露心血管不良事件的临床预测因素
本研究为前瞻性队列设计,基于毒物调查者联盟(ToxIC)登记库,纳入13,097例<18岁因疑似急性药物暴露接受毒理学家床旁评估的儿科急诊患者。主要结局为院内ACVE(心肌损伤、休克、室性心律失常或心脏骤停),发生278例(2.1%),院内死亡39例(0.3%)。多因素logistic回归显示,与青少年相比,<2岁(OR 0.41,95%CI 0.21-0.80)、2-6岁(OR 0.37,95%CI 0.21-0.80)、7-12岁(OR 0.51,95%CI 0.27-0.95)发生ACVE的可能性显著更低;血清碳酸氢盐<20 mEq/L(OR 2.31,95%CI 1.48-3.60)和QTc≥500 ms(OR 2.83,95%CI 1.67-4.79)与ACVE独立相关。结论认为成人药物过量人群推导的ACVE临床预测因素成功外推至该儿科人群,青少年年龄和阿片类药物暴露是与ACVE和死亡相关的新发现。
要点
- 儿科急性药物暴露患者中,血清碳酸氢盐<20 mEq/L与院内ACVE独立相关(OR 2.31,95%CI 1.48-3.60)。
- QTc≥500 ms与院内ACVE独立相关(OR 2.83,95%CI 1.67-4.79),为可床旁获取的风险标志。
- 与青少年相比,<2岁(OR 0.41,95%CI 0.21-0.80)、2-6岁(OR 0.37,95%CI 0.21-0.80)、7-12岁(OR 0.51,95%CI 0.27-0.95)发生ACVE的可能性显著更低。
- 青少年年龄和阿片类药物暴露是与ACVE和死亡相关的新发现。
- 13,097例中院内ACVE 278例(2.1%),院内死亡39例(0.3%)。
适用人群与场景
- 年龄<18岁的儿科患者,因疑似急性药物暴露在急诊就诊并接受毒理学家床旁评估,纳入ToxIC登记库。
诊断标准与关键阈值
- 血清碳酸氢盐<20 mEq/L为ACVE的独立相关因素(OR 2.31,95%CI 1.48-3.60)。
- QTc≥500 ms为ACVE的独立相关因素(OR 2.83,95%CI 1.67-4.79)。
研究设计与关键结果
- 前瞻性队列设计,基于ToxIC登记库,纳入13,097例儿科患者(58.5%女性),院内ACVE 278例(2.1%),院内死亡39例(0.3%)。
- 与青少年相比,<2岁OR 0.41(95%CI 0.21-0.80)、2-6岁OR 0.37(95%CI 0.21-0.80)、7-12岁OR 0.51(95%CI 0.27-0.95),发生ACVE的可能性显著更低。
- 血清碳酸氢盐<20 mEq/L与ACVE独立相关(OR 2.31,95%CI 1.48-3.60);QTc≥500 ms与ACVE独立相关(OR 2.83,95%CI 1.67-4.79)。
- 年龄和暴露药物类别(尤其是阿片类药物和心血管药物)与ACVE独立相关。
证据类型、等级与局限
- 证据类型:前瞻性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 对儿科急性药物暴露患者,可依据血清碳酸氢盐<20 mEq/L和QTc≥500 ms识别院内ACVE高风险者。
- 青少年年龄和阿片类药物暴露与ACVE和死亡相关,作者认为在阿片危机背景下这些发现迫切需进一步研究以应对青少年阿片过量相关的患病和死亡。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Context: Risk factors for adverse cardiovascular events (ACVE) from drug exposures have been well-characterized in adults but not studied in children. The objective of the present study is to describe the incidence, characteristics, and risk factors for in-hospital ACVEs among pediatric emergency department (ED) patients with acute drug exposures.Methods: This is a prospective cohort design evaluating patients in the Toxicology Investigators Consortium (ToxIC) Registry. Pediatric patients (age <18 years) who were evaluated at the bedside by a medical toxicologist for a suspected acute drug exposure were included. The primary outcome was in-hospital ACVE (myocardial injury, shock, ventricular dysrhythmia, or cardiac arrest). The secondary outcome was in-hospital death. Multiple logistic regression analyses were performed to examine novel clinical risk factors and extrapolate adult risk factors (bicarbonate <20 mEq/L; QTc ≥500 ms), for the primary/secondary outcomes.Results: Among the 13,097 patients (58.5% female), there were 278 in-hospital ACVEs (2.1%) and 39 in-hospital deaths (0.3%). Age and drug class of exposure (specifically opioids and cardiovascular drugs) were independently associated with ACVE. Compared with adolescents, children under 2 years old (OR: 0.41, 95% CI: 0.21-0.80), ages 2-6 (OR: 0.37, 95% CI: 0.21-0.80), and ages 7-12 (OR: 0.51, 95% CI: 0.27-0.95) were significantly less likely to experience an ACVE. Serum bicarbonate concentration <20 mEq/L (OR: 2.31, 95% CI: 1.48-3.60) and QTc ≥ 500 ms (OR: 2.83, 95% CI: 1.67-4.79) were independently associated with ACVE.Conclusion: Previously derived clinical predictors of ACVE from an adult drug overdose population were successfully extrapolated to this pediatric population. Novel associations with ACVE and death included adolescent age and opioid drug exposures. In the midst of the opioid crisis, these findings urgently warrant further investigation to combat adolescent opioid overdose morbidity and mortality.
参考来源
- Carreiro S, Miller S, Wang B, et al. Clinical predictors of adverse cardiovascular events for acute pediatric drug exposures. Clin Toxicol (Phila). 2019. PMID: 31267804. doi:10.1080/15563650.2019.1634272
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。